UK Health Security Agency
UK Health Security Agency is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Phase IIIb, Open-label, Multi-center Study to Evaluate the Immunogenicity and Safety of a Booster Dose and Describe the Immune Persistence of MenACYW Conjugate Vaccine with 5- and/or 10-year Booster Doses in Children and Adolescents who had been Primed with MenACYW Conjugate Vaccine as Toddlers
Sponsor Sanofi Winthrop Industrie
- Start (EU)
- Latest update
- Estimated end
- Not reported
A parallel-group, prevention, Phase III, modified double-blind, 2-arm, study to investigate the immunogenicity and describe the safety of a quadrivalent meningococcal conjugate vaccine (MenACYW conjugate vaccine) compared with Nimenrix® when administered in a 1+1 schedule in healthy infants and toddlers at 6 and 12 months of age
Sponsor Sanofi Pasteur
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available1 trial-level finding · Read insights
- The study enrolled 840 participants at 47 centers across six countries between 19 March 2024 and 14 November 2025.
These findings describe the trial, not the service provider’s performance or responsibility.
Questions about this trial experience
What services are recorded for UK Health Security Agency?
The 2026-10-09 snapshot links UK Health Security Agency to 2 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for UK Health Security Agency?
The most frequently recorded therapeutic areas are Infectious Disease. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to UK Health Security Agency conducted?
The linked trials record locations in 8 countries, including Germany, Finland, Czechia, Denmark, Spain. These are trial locations, not confirmed office locations or countries where UK Health Security Agency delivered services.
What can this page tell me about UK Health Security Agency's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under UK Health Security Agency. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- UK Health Security Agency